Immune checkpoint inhibitors (ICIs) as “chemotherapy (Ctx) sensitization” strategy in advanced solid tumours

Annals of Oncology - Tập 30 - Trang v519-v520 - 2019
F J Ros Montana1, I. Matos1, G. Vilacampa2, A. Azaro3, J. Martin-Liberal4, C. Hierro1, I. Brana3, C. Viaplana2, M Vieito Villar5, I. Gardeazabal1, C. Saura6, L Fariñas Madrid1, T Macarulla Mercade7, O. Saavedra3, N. Pardo1, M Ochoa de Olza8, E. Muñoz-Couselo1, J. Tabernero9, R. Dienstmann2, E. Garralda10
1Medical Oncology Deptartment, Vall d’Hebron University Hospital, Barcelona, Spain
2Oncology Data Science, Vall d'Hebron University Hospital, Barcelona, Spain
3Early Drug Develpment Unit, Vall d’Hebron University Hospital, Barcelona, Spain
4Early drug develpment Unit, Vall d`Hebron University Hospital Institut d’Oncologia, Barcelona, Spain
5Medical Oncology Deptartment, Vall d’Hebron University Hospital - Vall d’Hebron Institute of Oncology VHIO, Barcelona, Spain
6Medical Oncology Deptartment, Vall d`Hebron University Hospital Institut d’Oncologia, Barcelona, Spain
7Medical Oncology Deptartment, Vall d’Hebron Institute of Oncology (VHIO)-Cellex Center, Barcelona, Spain
8Early drug develpment Unit, ICO Institut Català d’Oncologia, Hospital Duran i Reynals, Barcelona, Spain
9Oncology, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
10Early drug Develpment Unit, Vall d`Hebron Institute of Oncology (VHIO)-Cellex Center, Barcelona, Spain

Thông tin
Thông tin xuất bản

Annals of Oncology

Tập 30

v519-v520

Thông tin tác giả